UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3783) 3783
science & technology (3075) 3075
life sciences & biomedicine (2964) 2964
male (2652) 2652
sildenafil citrate (1727) 1727
sulfones (1674) 1674
middle aged (1520) 1520
female (1380) 1380
sulfones - adverse effects (1323) 1323
adult (1231) 1231
sulfones - therapeutic use (1124) 1124
piperazines - therapeutic use (1118) 1118
aged (1097) 1097
purines (973) 973
piperazines - adverse effects (951) 951
lactones - adverse effects (885) 885
erectile dysfunction - drug therapy (873) 873
treatment outcome (737) 737
sildenafil (690) 690
animals (678) 678
abridged index medicus (617) 617
sulfones - administration & dosage (593) 593
phosphodiesterase inhibitors - therapeutic use (580) 580
double-blind method (565) 565
anti-inflammatory agents, non-steroidal - adverse effects (561) 561
cyclooxygenase inhibitors - adverse effects (558) 558
pharmacology & pharmacy (552) 552
urology & nephrology (519) 519
phosphodiesterase inhibitors - adverse effects (518) 518
sulfones - pharmacology (517) 517
piperazines - administration & dosage (465) 465
general & internal medicine (464) 464
lactones - therapeutic use (451) 451
medicine, general & internal (425) 425
purines - therapeutic use (421) 421
risk factors (394) 394
erectile dysfunction (391) 391
drug therapy (374) 374
celecoxib (357) 357
dose-response relationship, drug (353) 353
vasodilator agents - therapeutic use (341) 341
piperazines - pharmacology (340) 340
cyclooxygenase inhibitors - therapeutic use (337) 337
anti-inflammatory agents, non-steroidal - therapeutic use (329) 329
vardenafil dihydrochloride (312) 312
impotence (305) 305
sulfonamides - adverse effects (303) 303
cyclooxygenase 2 inhibitors - adverse effects (302) 302
administration, oral (296) 296
purines - adverse effects (291) 291
aged, 80 and over (284) 284
cardiovascular system & cardiology (276) 276
time factors (274) 274
prospective studies (266) 266
adolescent (261) 261
rofecoxib (255) 255
vasodilator agents - adverse effects (255) 255
rats (247) 247
hypertension, pulmonary - drug therapy (246) 246
care and treatment (242) 242
erectile dysfunction - etiology (242) 242
cyclooxygenase 2 (241) 241
cardiac & cardiovascular systems (236) 236
cyclooxygenase 2 inhibitors (231) 231
sulfonamides - therapeutic use (229) 229
membrane proteins (225) 225
research (225) 225
drug interactions (216) 216
drug therapy, combination (216) 216
medicine & public health (215) 215
analysis (214) 214
purines - administration & dosage (214) 214
imidazoles - therapeutic use (209) 209
united states (200) 200
randomized controlled trials as topic (196) 196
pyrazoles (194) 194
phosphodiesterase inhibitors - administration & dosage (192) 192
cross-over studies (186) 186
vasodilator agents - administration & dosage (183) 183
pyridines - adverse effects (182) 182
cyclooxygenase 2 inhibitors - therapeutic use (181) 181
mice (181) 181
cardiovascular diseases - chemically induced (179) 179
clinical trials as topic (175) 175
osteoarthritis - drug therapy (175) 175
clinical trials (172) 172
health aspects (171) 171
cox-2 inhibitors (168) 168
membranes, artificial (168) 168
phosphodiesterase inhibitors - pharmacology (168) 168
pulmonary hypertension (168) 168
lactones - administration & dosage (167) 167
tadalafil (166) 166
isoenzymes - antagonists & inhibitors (162) 162
pyridines - therapeutic use (162) 162
drug administration schedule (160) 160
follow-up studies (160) 160
triazines - therapeutic use (159) 159
blood pressure - drug effects (157) 157
purines - pharmacology (156) 156
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4028) 4028
German (123) 123
French (61) 61
Spanish (47) 47
Chinese (38) 38
Japanese (29) 29
Russian (16) 16
Portuguese (14) 14
Norwegian (11) 11
Dutch (10) 10
Italian (10) 10
Swedish (8) 8
Hebrew (7) 7
Finnish (6) 6
Czech (5) 5
Danish (5) 5
Polish (2) 2
Serbian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Hungarian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of sexual medicine, ISSN 1743-6095, 01/2013, Volume 10, Issue 1, pp. 130 - 171
Erectile dysfunction (ED) is the most frequently treated male sexual dysfunction worldwide. ED is a chronic condition that exerts a negative impact on male... 
Erectile Dysfunction | Phosphodiesterase Inhibitors | Vacuum Device Therapy | Oral Drug Treatment | Combination Therapies | Transurethral Alprostadil Therapy | Intracavernous Self-Injection Therapy | Intracavernous Self‐Injection Therapy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Phosphodiesterase 5 Inhibitors - adverse effects | Humans | Middle Aged | Sulfones - adverse effects | Male | Alprostadil - therapeutic use | Erectile Dysfunction - therapy | Aged, 80 and over | Imidazoles - therapeutic use | Imidazoles - adverse effects | Risk Factors | Phosphodiesterase 5 Inhibitors - administration & dosage | Alprostadil - adverse effects | Yohimbine - adverse effects | Piperazines - therapeutic use | Sulfones - pharmacokinetics | Carbolines - administration & dosage | Piperazines - adverse effects | Sulfonamides - pharmacokinetics | Yohimbine - therapeutic use | Tadalafil | Vardenafil Dihydrochloride | Pyrimidines - pharmacokinetics | Hypogonadism - therapy | Triazines - adverse effects | Sulfonamides - administration & dosage | Sulfones - administration & dosage | Triazines - pharmacokinetics | Piperazines - administration & dosage | Sulfones - therapeutic use | Age Factors | Triazines - therapeutic use | Imidazoles - administration & dosage | Imidazoles - pharmacokinetics | Phosphodiesterase 5 Inhibitors - pharmacokinetics | Alprostadil - administration & dosage | Erectile Dysfunction - drug therapy | Penile Erection - drug effects | Adult | Phosphodiesterase 5 Inhibitors - therapeutic use | Piperazines - pharmacokinetics | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Pyrimidines - administration & dosage | Erectile Dysfunction - etiology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Triazines - administration & dosage | Hypogonadism - complications | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Aged | Carbolines - pharmacokinetics | Hypertension | Care and treatment | Conservatism | Online health care information services | Impotence | Prosthesis | Chronic diseases | Risk factors | Testosterone | Implants, Artificial | Prostaglandins E | Diabetes | Vasoactive intestinal peptides | Special education | Index Medicus
Journal Article
2005, Volume 65, Issue 12, 30
.... Phosphodiesterase Type 5 Inhibitors ...1625 2.1 Sildenafil ...1625 2.1.1 Pharmacokinetics and Dose Administration ...1625 2.1.2 Efficacy ...1625 2.1.3 Adverse Events... 
Phosphodiesterase IV inhibitors | Erectile dysfunction | Erectile devices | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Phosphodiesterase Inhibitors - therapeutic use | Sulfones - therapeutic use | Phentolamine - adverse effects | Phentolamine - therapeutic use | Phosphodiesterase Inhibitors - adverse effects | Triazines - therapeutic use | Vasodilator Agents - therapeutic use | Humans | Dopamine Agonists - therapeutic use | Sulfones - adverse effects | Male | Dopamine Agonists - adverse effects | Apomorphine - therapeutic use | Apomorphine - adverse effects | Contraindications | Patient Satisfaction | Sildenafil Citrate | Penis - drug effects | Purines | Regional Blood Flow - drug effects | Alprostadil - therapeutic use | Erectile Dysfunction - drug therapy | Erectile Dysfunction - therapy | Treatment Failure | Imidazoles - therapeutic use | Papaverine - therapeutic use | Carbolines - therapeutic use | Penis - blood supply | Carbolines - adverse effects | Papaverine - adverse effects | Penile Prosthesis | Constriction | Administration, Oral | Imidazoles - adverse effects | Alprostadil - adverse effects | Piperazines - therapeutic use | Enzyme Inhibitors - therapeutic use | Piperazines - adverse effects | Tadalafil | Vardenafil Dihydrochloride | Triazines - adverse effects | Vasodilator Agents - adverse effects | Vasodilator Agents - administration & dosage | Drug Combinations | Index Medicus
Book Review
Journal Article
Annals of internal medicine, ISSN 0003-4819, 10/2008, Volume 149, Issue 8, pp. 521 - 530
Journal Article